Biohaven and SK Biopharmaceuticals sign global licensing deal
Biohaven and SK Biopharmaceuticals entered into a strategic global licensing agreement for a Kv7 ion channel platform and opakalim for epilepsy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.